Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I (2021) The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 9:622–642
Article CAS PubMed PubMed Central Google Scholar
Adam D (2022) COVID’s true death toll: much higher than official records. Nature 603(7902):562
Article CAS PubMed Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810
Article CAS PubMed PubMed Central Google Scholar
Vincent JL (2021) COVID-19: it’s all about sepsis. Future Microbiol 16:131–133
Article CAS PubMed Google Scholar
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, Fleischmann-Struzek C, Pletz MW, Netea MG, Reinhart K, Kyriazopoulou E (2021) Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med 49(12):2042–2057
CAS PubMed PubMed Central Google Scholar
Herminghaus A, Osuchowski MF (2022) How sepsis parallels and differs from COVID-19. EBioMedicine 86:104355
Article PubMed PubMed Central Google Scholar
Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C; Explore COVID-19 IPH group; Explore COVID-19 Marseille Immunopole group; Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E (2020) Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature 588(7836):146–150
Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, Ward PA (1999) Protective effects of C5a blockade in sepsis. Nat Med 5(7):788–792
Article CAS PubMed Google Scholar
Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, Zheng M, Sundaram B, Banoth B, Malireddi RKS, Schreiner P, Neale G, Vogel P, Webby R, Jonsson CB, Kanneganti TD (2021) Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell 184(1):149–168
Article CAS PubMed Google Scholar
Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA (1992) Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 149(5):1666–1670
Article CAS PubMed Google Scholar
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Across Speciality Collaboration HLH, UK, (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034
Article CAS PubMed PubMed Central Google Scholar
Mangalmurti N, Hunter CA (2020) Cytokine Storms: Understanding COVID-19. Immunity 53(1):19–25
Article CAS PubMed PubMed Central Google Scholar
Sinha P, Matthay MA, Calfee CS (2020) Is a “cytokine storm” relevant to COVID-19? JAMA Intern Med 180(9):1152–1154
Article CAS PubMed Google Scholar
Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, Blood TM, Mudd PA, Yi DJ, Mannion DA, Osborne DF, Martin RS, Anand NJ, Bosanquet JP, Blood J, Drewry AM, Caldwell CC, Turnbull IR, Brakenridge SC, Moldwawer LL, Hotchkiss RS (2020) Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight 5(17):e140329
Article PubMed PubMed Central Google Scholar
Kox M, Waalders NJB, Kooistra EJ, Gerretsen J, Pickkers P (2020) Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA 324(15):1565–1567
Article CAS PubMed PubMed Central Google Scholar
Stolarski AE, Kim J, Zhang Q, Remick DG (2021) Cytokine drizzle-the rationale for abandoning “cytokine storm.” Shock 56(5):667–672
Article CAS PubMed Google Scholar
Cavaillon JM, Munoz C, Fitting C, Misset B, Carlet J (1992) Circulating cytokines: the tip of the iceberg? Circ Shock 38(2):145–152
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497–506
Article CAS PubMed Google Scholar
Zhou Z, Ren L, Zhang L, Zhong J, Xiao Y, Jia Z, Guo L, Yang J, Wang C, Jiang S, Yang D, Zhang G, Li H, Chen F, Xu Y, Chen M, Gao Z, Yang J, Dong J, Liu B, Zhang X, Wang W, He K, Jin Q, Li M, Wang J (2020) Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe 27(6):883–890.e2
Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, Guo D, Hu W, Yang J, Tang Z, Wu H, Lin Y, Zhang M, Zhang Q, Shi M, Liu Y, Zhou Y, Lan K, Chen Y (2020) Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect 9(1):761–770
Article CAS PubMed PubMed Central Google Scholar
Schuurman AR, Reijnders TDY, van Engelen TSR, Léopold V, de Brabander J, van Linge C, Schinkel M, Pereverzeva L, Haak BW, Brands X, Kanglie MMNP, van den Berk IAH, Douma RA, Faber DR, Nanayakkara PWB, Stoker J, Prins JM, Scicluna BP, Wiersinga WJ, van der Poll T (2022) The host response in different aetiologies of community-acquired pneumonia. EBioMedicine 81:104082
Article CAS PubMed PubMed Central Google Scholar
Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163(2):316–321
Article CAS PubMed Google Scholar
Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fitting C (2001) Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotoxin Res 7(2):85–93
Cavaillon JM (2002) “Septic plasma”: an immunosuppressive milieu. Am J Respir Crit Care Med 166(11):1417–1418
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644–1655
Article CAS PubMed Google Scholar
Masi P, Hékimian G, Lejeune M, Chommeloux J, Desnos C, Pineton De Chambrun M, Martin-Toutain I, Nieszkowska A, Lebreton G, Bréchot N, Schmidt M, Edouard Luyt C, Combes A, Frere C (2020) Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: insights from a prospective, single-center cohort study. Circulation 142(6):611–614
Article CAS PubMed PubMed Central Google Scholar
Boehme AK, Doyle K, Thakur KT, Roh D, Park S, Agarwal S, Velazquez AG, Egbebike JA, Der Nigoghossian C, Prust ML, Rosenberg J, Brodie D, Fishkoff KN, Hochmann BR, Rabani LE, Yip NH, Panzer O, Claassen J (2022) Disorders of consciousness in hospitalized patients with COVID-19: the role of the systemic inflammatory response syndrome. Neurocrit Care 36(1):89–96
Article CAS PubMed Google Scholar
Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112(1):235–243
Article CAS PubMed Google Scholar
Adib-Conquy M, Cavaillon JM (2009) Compensatory anti-inflammatory response syndrome. Thromb Haemost 101(1):36–47
Article CAS PubMed Google Scholar
Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA (2001) Post-injury multiple organ failure: the role of the gut. Shock 15(1):1–10
Article CAS PubMed Google Scholar
Reddy RC, Chen GH, Tekchandani PK, Standiford TJ (2001) Sepsis-induced immunosuppression: from bad to worse. Immunol Res 24(3):273–287
Article CAS PubMed Google Scholar
Nomikos IN, Vamvakopoulos NC (2001) Correlating functional staging to effective treatment of acute surgical illness. Am J Surg 182(3):278–286
Article CAS PubMed Google Scholar
Riedemann NC, Guo RF, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9(5):517–524
Article CAS PubMed Google Scholar
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138–150
Article CAS PubMed Google Scholar
Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15(5):496–497
Comments (0)